amycretin vs tirzepatide What is the pipeline for future medications for obesity? Retatrutide vs Amycretin: Why This

When BCBS covers Zepbound, typical PA requirements include: BMI 30 or 27 with a comorbidity (hypertension, type 2 diabetes, high cholesterol, or OSA), 6 months of documented lifestyle modification (diet and exercise program), and sometimes step therapy requiring trial of other weight loss medications first

I learned a lot doing it

Retatrutide An investigational triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors, demonstrating body-weight change of up to 24.2% in phase 2 trials alongside improvements in cardiometabolic parameters and hepatic steatosis

#Gliprons #GLP1 #SmallMolecule #DrugDiscovery #Orforglipron #MedicinalChemistry #Semaglutide Update : You may connect us for Orforglipron Intermediates Recent Update : HRS-7535 (also known as KAI-7535 or Safiglipron) is an oral, small-molecule GLP-1 receptor agonist originally developed by Jiangsu Hengrui Pharmaceuticals Co., Ltd

[DOI] [PubMed] [Google Scholar] 90.Torres-Mora J., Dry S., Li X., Binder S., Amin M., Folpe A.L